Extracellular HIV-1 TAT protein induces the rapid ser133 phosphorylation and activation of CREB transcription factor in both jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3891-3898

  Gibellini, Davide ^a   Bassini, Alessandra ^b   Pierpaoli, Sabina ^b   Bertolaso, Lucia ^b   Milani, Daniela ^b   Capitani, Silvano ^b   La Placa, Michele ^a   Zauli, Giorgio ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STAUROSPORINE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONSENSUS SEQUENCE; ELECTROPHORETIC MOBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEUKEMIA CELL LINE; LYMPHOID CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BASE SEQUENCE; BINDING SITES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; ENZYME INHIBITORS; FLAVONOIDS; GENE PRODUCTS, TAT; GENES, REPORTER; HIV-1; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; SERINE; SIGNAL TRANSDUCTION; STAUROSPORINE; TRANSFECTION;

EID: 0032522663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Jones, K. A., and M. B. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717.
2. Roy, S., U. Delling, C. H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated transactivation. Genes Dev. 4:1365.
3. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, M. A. Skinner, and R. Valerio. 1989. HIV-1 tat protein binds transactivation-response region (TAR) in vitro. Proc. Natl. Acad. Sci. USA 86:6925.
4. Koken, S. E. C., A. E. Greijer, K. Verhoef, J. van Wamel, A. G. Bukrinskaya, and B. Berkout. 1994. Intracellular analysis of in vitro-modified HIV Tat protein. J. Biol. Chem. 269:8366.
5. Dang, C. V., and W. M. F. Lee. 1989. Nuclear and nucleolar targeting sequences of c-erb-A, c-myc, N-myc, p53, HPS70, and HIV tat proteins. J. Biol. Chem. 264:18019.
6. Ensoli, B., G. Barillari, S. Zaki Salahuddin, R. C. Gallo, and F. Wong-Stall. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345:84.
7. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J. Virol. 67:277.
8. Milani, D., G. Zauli, L. M. Neri, M. Marchisio, M. Previati, and S. Capitani. 1993. Influence of the human immunodeficiency virus type 1 tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen. Virol. 74:2587.
9. Zauli, G., M. La Placa, M. Vignoli, M. C. Re, D. Gibellini, G. Furlini, D. Milani, M. Marchisio, M. Mazzoni, and S. Capitani. 1995. An autocrine loop of HIV type 1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J. AIDS 10:408.
10. Zauli, G., D. Gibellini, D. Milani, M. Mazzoni, P. Borgatti, M. La Placa, and S. Capitani 1993. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:4481.
11. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 246:1606.
12. Subramanyam, M., W. G. Gutheil, W. W. Bachovchin, and B. T. Huber. 1993. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150:2544.
13. Chirmule, N., S. Than, S. A. Khan, and S. Pahwa. 1995. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol. 69:492.
14. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
15. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:229.
16. Purvis S. F., J. W. Jacobberger, R. M. Sramkoski, A. H. Patki, and M. M. Lederman. 1995. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses 11:443.
17. McCloskey T. W., M. Ott, E. Tribble, S. A. Khan, S. Teichberg, M. O. Paul, S. Pahwa, E. Verdin, and N. Chirmule. 1997. Dula role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158:1014.
18. Zauli, G., D. Gibellini, A. Caputo, A. Bassini, M. Negrini, M. Monne, M. Mazzoni, and S. Capitani. 1995. The human immunodeficiency virus type-1 (HIV-1) Tat protein upregulates Bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood 86:3823.
19. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189.
20. Mann, D. A., and A. D. Frankel. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1733.
21. Bonifaci, N., R. Sitia, and A. Rubartelli. 1995. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 9:995.
22. Fawell, S., J. Seery, Y. Daikh, C. Moore, L. L. Chen, B. Pepinsky, and J. Barsoum. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91:664.
23. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokine. J. Virol. 66:7159.
24. Zauli, G., B. R. Davis, M. C. Re, G. Visani, G. Furlini, and M. La Placa. 1992. Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for HIV-1 induced hematopoietic suppression. Blood 80:3036.
25. Scala, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta. 1994. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 tat protein. J. Exp. Med. 179:961.
26. Westendorp, M. O., M. Li-Weber, R. W. Frank, and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177.
27. Sharma, V., T. J. Knobloch, and D. Benjamin. 1995. Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem. Biophys. Res. Commun. 208:704.
28. Flores, S. C., J. C. Marecki, K. P. Harper, S. K. Bose, S. K. Nelson, and J. M. McCord. 1993. Tat protein of HIV-1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90:7632.
29. Li, C. J., C. Wang, D. J. Friedman, and A. B. Pardee. 1995. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:5461.
30. Brake, D. A., C. Debouck, and G. Biesecher. 1990. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein. Tat. J. Cell. Biol. 111:1275.
31. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same types by using integrin receptors recognizing RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
32. 5 integrin to tha basic domain of the HIV tat protein and vitronectin. J. Cell. Biol. 121:461.
33. Weeks, B. S., K. Desai, P. M. Loewenstein, M. E. Klotman, P. Klotman, M. Green, and H. K. Kleinman. 1993. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J. Biol. Chem. 268:5279.
34. + T lymphocytes. J. Immunol. 157:2216.
35. Albini, A., R. Soldi, D. Giunciuglio, E. Giraudo, R. Benelli, L. Primo, D. Noonan, M. Salio, G. Camussi, W. Rocki, and F. Bussolino. 1996. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-KDR receptor on vascular endothelial cells. Nat. Med. 2:1371.
36. Milani, D., M. Mazzoni, P. Borgatti, G. Zauli, L. Cantley, and S. Capitani. 1996. Extracellular human immunodeficiency virus type-1 (HIV-1) Tat protein activates PI-3 kinase in PC12 neuronal cells. J. Biol. Chem. 271:22961.
37. Conant K., M. Ma, A. Nath, and E. Major. 1996. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1384.
38. Celeghini, C., M. Marchisio, C. Mischiati, L. Bertolaso, S. Capitani, and G. Zauli. 1996. In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity. Int. J. Oncol. 8:349.
39. Lalli, E., and P. Sassone-Corsi. 1994. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269:17359.
40. Sassone-Corsi, P. 1995. Transcription factors responsive to cAMP. Annu. Rev. Cell. Dev. Biol. 11:355.
41. Ginty, D. D., A. Bonni, and M. E. Greenberg. 1993. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77:713.
42. Yamamoto, K. K., G. A. Gonzalez, W. H. Biggs, and M. R. Montminy. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494.
43. Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675.
44. Roesler, W. J., G. R. Vanderbark, and R. W. Hanson. 1988. Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263:9063.
45. Montminy, M. R., G. A. Gonzalez, and K. K. Yamamoto. 1990. Regulation of cAMP-inducible genes by CREB. Trends Neurosci. 13:184.
46. Blendy, J. A., K. H. Kaestner, W. Schmidt, P. Gass, and G. Schutz. 1996. Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform. EMBO J. 15:1098.
47. Barton, K., N. Muthusamy, M. Chanyangam, C. Fischer, C. Clendenin, and J. M. Leiden. 1996. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 379:81.
48. Feuerstein, N., D. Huang, S. H. Hinrichs, D. J. Orten, N. Aiyar, and M. B. Prystowsky. 1995. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2. J. Immunol. 154:68.
49. Dignam, J. D., R. M Lebovitz, and R. G. Roeder. 1983. RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
50. Laoidc, B. M., N. S. Foulkes, F. Schlotter, and P. Sassone-Corsi. 1993. The functional versatility of CREM is determined by its modular structure. EMBO J. 12:1179.
51. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427.
52. Webster, N., Jin, J. R., Green, S., Hollis, M., and P. Chambon. 1988. The yeast UASG is a transcriptional enhancer in human HeLa cells. Cell 52:169.
53. Kriegler, M. 1990. Gene Transfer and Expression. Stockton Press, New York, pp. 85, 102.
54. Arcaro, A., and M. P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3, 4,5-trisphosphate in neutrophil responses. Biochem. J. 296:297.
55. Mignacca, R. C., H. J. J. Lee, E. M. Kwon, and K. M. Sakamoto. 1996. Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321. Blood 88:848.
56. Xing, J., D. D. Ginty, and M. E. Greenberg. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959.
57. Rabbi, M. F., M. Saifuddin, G. De Sheng, M. F. Kagnoff, and K. A. Roebuck. 1997. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Virology 233:235.
58. Gibellini, D., A. Caputo, S. Capitani, M. La Placa, and G. Zauli. 1997. Upregulation of c-fos in activated T lymphoid and monocytic cells by human Immunodeficiency virus 1 Tat protein. Blood 89:1654.
59. Li, C. J., Y. Ueda, B. Shi, L. Borodyansky, L. Huang, Y. Z. Li, and A. B. Pardee. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc. Natl. Acad. Sci. USA 94:8116.
60. Menegon, A., C. Leoni, F. Benfenati, and F. Valtorta. Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem. Biphys. Res. Commun. 238:800.